Mycoplasma Diagnostics Market Analysis, Applications Share, Trends & Forecast to 2024
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests. But decline in cost per sample analysis and labor cost, improvements in automation and introduction of advanced technologies has extended the usage of molecular diagnostics in wide range of applications. The market for mycoplasma diagnostics has expanded since 1990’s with the introduction of PCR. It is estimated that in the U.S. over 600 laboratories and 200 independent laboratories perform mycoplasma diagnostics test to simplify and accelerate the testing process.
The global mycoplasma diagnostics market, which stood at US$602.0 mn in 2016, is forecast to reach US$1.35 bn by the end of 2024. If these figures hold true, the market will exhibit a CAGR of 10.6% between 2016 and 2024.
Demand for Software & Services Projected to Increase at High Pace
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
View Report @ http://www.transparencymarketresearch.com/mycoplasma-diagnostics-market.html
By technology, PCR, immunoassay, DNA staining, microbial culture techniques and others are the key market segments. Currently, the PCR segment contributes the largest share in the revenue generated by the market based on technology. The demand for PCR is forecast to increase considerably in the coming years owing to the rising incidence of hospital acquired infections. The diagnostic technology provides rapid turnaround time, reduction in cost of sequencing, and sensitivity. As end users get to know benefits offered by PCR, the demand from the segment will increase in response.
By end users, global mycoplasma diagnostic market is dominated by hospitals & diagnostic laboratories. Hospitals & diagnostic laboratories are an importantchannel for the usage of multiplexed diagnostic products & offer a range of diagnosis solutions. They are an important channel for the usage of multiplexed diagnostic products. According to the norms of government health care facilities, they offer reimbursement plans and advanced technology systems for treatment.
North America Holds Dominance, But Asia Pacific to Report Higher CAGR
Regionally, North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa constitute the key market segments. Among these regions, North America held dominance in 2016 with an estimated share of 35.4% in the overall market. Several large research laboratories are present in North America. Besides this, the region also boasts a high level of public awareness, which provides an environment conducive to the growth of the mycoplasma diagnostics market. Furthermore, in the coming years, the market is expected to gain from the increasing demand for point of care testing.
Despite dominance exercised by the North America market, during the forecast period Asia Pacific will showcase more lucrative opportunities. Besides the high incidence of respiratory tract infection witnessed in the last few years, the emerging nations in the region boasts high healthcare spending, which has helped the mycoplasma market exhibit strong growth in Asia Pacific. In addition, the regional market is forecast to gain from the rising demand for personalized medicines, rise in research and development investments, and the rising public awareness.
Key players operating in this market include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc. among others.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving mycoplasma diagnostics market during 2016 - 2024
Get accurate market forecast and analysis on the mycoplasma diagnostics market. Request a sample to stay abreast on the key trends impacting this market.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mycoplasma Diagnostics Market Analysis, Applications Share, Trends & Forecast to 2024 here
News-ID: 524726 • Views: 412
More Releases from Transparency Market Research
Understanding Impact of COVID-19 on Syngas and Derivatives Market
A new study by Transparency Market Research (TMR) states that the degree of competition between BASF SE, Air Liquide SA, Sasol Ltd., and The Linde Group defines the competitive landscape of the global syngas and derivatives market . Over the coming years, the rivalry between these players is likely to increase substantially due to their rising involvement in mergers, acquisitions, and partnerships. According to the research report, the overall consumption
Analysis of Potential Impact of COVID-19 on Containerized Solar Generators Marke …
The global containerized solar generators market prognosticated to witness a robust growth in coming years. The nearness of a few players renders a high level of discontinuity and extreme aggressive contention among market players in the worldwide containerized solar generators market, as researched by Transparency Market Research (TMR) in another report. According to the report, HCI Energy LLC, Ecosphere Technologies Inc., Photon Energy NV, AMERESCO Inc., REC Solar Holdings AS,
Generator (Up to 20 kVA) Market Forecast and Segments 2019-2027
Global Generator (Up to 20 kVA) Market: Key Highlights The global generator (up to 20 kVA) market was valued at ~US$ 2.2 Bn in 2018, and is anticipated to expand at a CAGR of 5.5% during the forecast period. Among the fuel types, the diesel segment accounted for a major share of the global generator (up to 20 kVA) market in 2018. Diesel generators are the primarily employed generators across the globe. Among
Industrial Protective Clothing Fabrics Market Trends and Segments 2019-2027
Global Industrial Protective Clothing Fabrics Market: Highlights The global industrial protective clothing fabrics market is projected to grow at a CAGR of nearly 7% between 2019 and 2027. Enforcement of stringent safety regulations for workers at public sector coupled with various bills passed by regulatory authorities is likely to propel global industrial protective clothing fabrics market. A growing consciousness inside the industrial sector in various emerging economies with regards to workplace
More Releases for Mycoplasma
Mycoplasma Diagnostics Market Opportunity Analysis by 2024
The global market for mycoplasma disorder featured the top five vendors, namely Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Merck KGaA, Agilent Technologies, and Lonza Group accounting for over 68% of the overall market in 2016, observes Transparency Market Research (TMR) in a recent report. The high level of consolidation has ensued intense competition and increased focus of leading vendors on mergers and acquisitions, geographical expansion, and introduction of technologically
Mycoplasma Diagnostics Market to Reach US$ 1.35 Billion in 2024
Transparency Market Research states that the global mycoplasma diagnostics market will expand at a promising 10.6% CAGR over the period between 2016 and 2024, rising from a valuation of US$602.0 mn in 2016 to US$1.35 bn in 2024. The vast rise in the rate of prevalence of respiratory tract infections has emerged as the key growth driver for the global mycoplasma diagnostics market in the past few years. A report
Mycoplasma Diagnostics Market - Positive long-term growth outlook 2016 - 2024
The global mycoplasma diagnostics market will expand at a promising 10.6% CAGR over the period between 2016 and 2024, rising from a valuation of US$602.0 mn in 2016 to US$1.35 bn in 2024. In terms of the key end users of mycoplasma diagnostics devices and consumables, the segment of hospitals is presently the dominant demand and revenue generator. The segment accounted for a nearly 33% of the overall mycoplasma disorder market
Mycoplasma Diagnostics Market Demand is Increasing
Global Mycoplasma Diagnostics Market: Snapshot Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost
Global Mycoplasma Diagnostics Market Analysis
Albany, New York, May 3, 2017: This report on Mycoplasma Diagnostics Studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various mycoplasma techniques and products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of
Global Mycoplasma Testing Market Research Report 2017
Qyresearchreports include new market research report "Global Mycoplasma Testing Market Research Report 2017" to its huge collection of research reports. Various factors are responsible for the high revenue growth witnessed in the global Mycoplasma Testing market. However there are a few restraints as well forecast to challenge the market’s trajectory. Nevertheless, through the course of the forecast period starting from 2016 to 2021, the market will continue exhibiting steady growth. The